Skip to main content

Your search for “CIRM” returned 64 results

UC San Diego Cancer Researchers Receive $4 Million CIRM Disease-Team Grant

December 13, 2013

Researcher Thomas J. Kipps, MD, PhD, professor of medicine and deputy director of research operations at UC San Diego Moores Cancer Center, is principal investigator for one of six “Disease Team” awards approved December 12 by the governing board of the California Institute for Regenerative Medicine (CIRM).

Two UC San Diego Scientists Receive Stem Cell Technology Grants

February 2, 2015

The governing board of the California Institute for Regenerative Medicine (CIRM) has awarded two University of California, San Diego researchers almost $3 million in combined funding to pursue new technologies intended to accelerate advances moving stem cell therapies out of the lab and into the clinic.

UC San Diego Research Funded By CIRM to Identify Potential Autism Drug Targets

August 28, 2013

A researcher at the University of California, San Diego School of Medicine is among principal investigators at 10 California institutions receiving Early Translational IV Research grants, totaling $40 million, approved today by the governing board of the California Institute for Regenerative Medicine (CIRM) at its meeting in San Diego.

Three UC San Diego Researchers Receive New CIRM Grants

March 19, 2013

Researchers at the University of California, San Diego School of Medicine are principal investigators in two of nine new grants approved today by the governing board of the California Institute for Regenerative Medicine (CIRM).

Scientists Receive $4.8M to Pursue Gene Therapy for ‘Incurable’ Disease

December 1, 2022

The California Institute for Regenerative Medicine has awarded UC San Diego researchers $4.8 million to advance a gene therapy to treat Friedreich’s ataxia, a rare but devastating neuromuscular disorder.

State’s Stem Cell Agency Awards Nearly $8 Million for New Leukemia Therapies

December 1, 2017

The Independent Citizens Oversight Committee of the California Institute for Regenerative Medicine (CIRM) unanimously approved yesterday two grants worth a total of almost $8 million to University of California San Diego School of Medicine researchers investigating novel stem cell-based treatments for acute myeloid leukemia or AML.

UC San Diego Researchers Receive Funding to Pursue Novel Stem Cell-based Treatments

July 20, 2018

…governing board of the California Institute for Regenerative Medicine (CIRM) unanimously approved this week two grants worth more than $2.2 million to University of California San Diego School of Medicine researchers investigating stem cell-based therapies for a rare genetic disorder that affects the heart and a chronic, progressive affliction of…

UC San Diego Researcher Funded for Stem-Cell-based Preeclampsia Therapies

December 12, 2012

Dr. Mana Parast, an assistant professor of pathology at the University of California, San Diego School of Medicine, has been awarded a $3 million grant to continue her research into new therapies for preeclampsia, a pregnancy complication that often results in additional neonatal complications.

CIRM Approves $5.8 Million Grant for CAR-T Therapy that Targets Cancer Stem Cells

July 20, 2017

…Institute for Regenerative Medicine (CIRM) today unanimously approved a $5.8 million award to University of California San Diego School of Medicine researchers to develop a new immunotherapy in which patients’ cells would be equipped with a special receptor that recognizes and targets cancer stem cells, whose survival abilities often render…

CIRM Approves New Funding to UC San Diego Researchers Fighting Zika Virus and Cancer

January 20, 2017

…Institute for Regenerative Medicine (CIRM) has approved a pair of $2 million awards to University of California San Diego School of Medicine researchers to advance studies of new treatments for Zika virus infections and the use of stem cell-derived natural killer (NK) cells to target ovarian cancer and other malignancies.

Category navigation with Social links